iSpecimen, a Lexington, Massachusetts-based company in the healthcare and life sciences sector, announced on Wednesday that it has laid off approximately 20% of its workforce effective immediately. This workforce reduction is part of a strategic effort to cut costs and drive profitability amid financial challenges, as reflected in the company's stock, which has declined nearly 53% year-to-date. The layoffs, impacting a significant portion of its employees, underscore the company's focus on streamlining operations to navigate current market conditions.
